Applied BioMath, LLC Announces Participation at the Cytokine-Based Cancer Immunotherapies Summit

Applied BioMath ( www.appliedbiomath.com (link is external) ), the industry-leader in providing model-informed drug discovery and development (MID3) support to help accelerate and de-risk therapeutic research and development (R&D), today announced their participation at the Cytokine-Based Cancer Immunotherapies Summit occurring November 30

Related Keywords

Boston ,Massachusetts ,United States ,Fei Hua ,John Burke ,Simulation Services At Applied Biomath ,Development Of Immunocytokines ,Applied Biomath ,Simulation Services ,Quantitative Systems Pharmacology ,Bioinformatics ,Biotechnology ,Cancer ,Clinical Pharmacology ,Clinical Research ,Clinical Trial ,Computer ,Drug Discovery ,Health Sciences ,Pharmaceutical Industry ,Pharmacology ,Simulation ,Software Development ,Academic Disciplines ,Articles ,Biosimulation ,Pharmacokinetics ,Systems Biology ,